Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Bernardo Meza-Torres

Researcher

Bernardo is a postdoctoral researcher at the Clinical Informatics and Health Outcomes Research Group (CIHORG) at the University of Oxford. His research focuses on developing quality indicators by leveraging real-world evidence from large-scale routine databases derived from electronic health records. His postdoctoral work has been pivotal in examining the impact of organizational arrangements on the care of individuals with type-2 diabetes and chronic liver disease, utilizing advanced statistical methods such as multistate modelling, and fit-for-purpose composite indicators.

Bernardo holds a medical degree from the National Autonomous University of Mexico (UNAM). He furthered his education with masters in Health Economics and Bioethics from the Universities of Heidelberg and KU Leuven. Bernardo was awarded a DPhil in Medicine and Biosciences by the University of Surrey in 2022, as part of the EU Horizon 2020 HealthPros consortium. His professional background includes roles as a health-economics consultant in the Mexican healthcare industry. In the NGO sector, Bernardo implemented digital technologies for monitoring non-communicable diseases in Mexico, and collaborated with the UNICEF Innovation Fund for the monitoring resource use in Latin America.

His research interests include the evaluation of healthcare delivery and outcomes; development and validation of quality indicators; research of non-communicable diseases; and health economics and outcome research.

Relevant publications (ORCID)

Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions. 2024. 10.1016/S1473-3099(24)00352-9

Adherence to General Diabetes and Foot Care Processes, with Prompt Referral, Are Associated with Amputation-Free Survival in People with Type 2 Diabetes and Foot Ulcers: A Scottish National Registry Analysis. 2022. 10.1155/2022/7414258

Health service organisation impact on lower extremity amputations in people with type 2 diabetes with foot ulcers: systematic review and meta-analysis. 2021. s00592-020-01662-x

Differences in Clinical Presentation With Long COVID After Community and Hospital Infection and Associations With All-Cause Mortality: English Sentinel Network Database Study. 2022. 10.2196/37668

Developing a Long COVID Phenotype for Postacute COVID-19 in a National Primary Care Sentinel Cohort: Observational Retrospective Database Analysis. 2022. 10.2196/36989

Hepatitis A Vaccination Coverage Among People With Chronic Liver Disease in England (HEALD): Protocol for a Retrospective Cohort Study. DOI: 10.2196/51861

The experiences of 33 national COVID-19 dashboard teams during the first year of the pandemic in the World Health Organization European Region: A qualitative study. 2022. 10.1177/20552076221121154

Features Constituting Actionable COVID-19 Dashboards: Descriptive Assessment and Expert Appraisal of 158 Public Web-Based COVID-19 Dashboards. 2021. 10.2196/25682

Trends in diabetes medication use in Australia, Canada, England, and Scotland: A repeated cross-sectional analysis in primary care. 2021. DOI: 10.3399/bjgp20X714089

Development and validation of a modified Cambridge Multimorbidity Score for use with internationally recognized electronic health record clinical terms (SNOMED CT); 2023.  10.3399/BJGP.2022.0235

Hepatitis B virus infection in general practice across England: An analysis of the Royal College of General Practitioners Research and Surveillance Centre real-world database. 2023. 10.1016/j.jinf.2023.03.001.